Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose:
MicroRNA (MiR-) 146a is a key regulator of the innate immune response and has also been shown to suppress cancer development in myeloid cells. Elevated expression of miR-146a has been detected in synovial tissue of rheumatoid arthritis patients, but its role in the development of inflammatory arthritis is yet unknown.
Methods:
We induced K/BxN serum transfer arthritis in wild type and miR-146a-/- mice. As a second inflammatory arthritis model we crossed miR-146a deficient into hTNFtg mice. Disease severity was assessed clinically and histologically in both arthritis models. Blood of arthritis animals was analyzed by flow cytometry. Serum cytokine levels were measured by Elisa.
Results:
Absence of miR-146a leads to increased clinical signs of the induced serum transfer arthritis. In line, higher serum levels of the proinflammatory cytokines IL12 and TNF were measured in miR146a deficient mice compared to wt mice. When we crossed miR-146a-/- mice into hTNFtg mice, while detecting no clinical difference between hTNFtg and miR-146a/hTNFtg mice, we found a significant increase in circulating CD11b+ myeloid cells as well as CD11c+ dendritic cells in blood of miR-146a-/-/hTNFtg mice compared to hTNFtg mice. Histological examination revealed a significant increase in synovial inflammation miR-146a-/-/hTNFtg mice compared to hTNFtg mice. Even more striking, miR-146a-/-/hTNFtg mice displayed a more than twofold increase in local bone destruction which was due to increased generation of osteoclasts in the tarsal joints of the mice. Measuring cytokine levels in serum, we show that IL-1β levels are increased in mice lacking miR-146a.
Conclusion:
These data clearly demonstrate a negative regulatory role of the miR-146a in inflammatory arthritis. During arthritis, miR-146a is centrally involved in the regulation of proinflammatory cytokines as well as local bone destruction. These results identify an important anti-inflammatory role of miR-146a, which might possibly be exploited for therapeutic purposes.
Disclosure:
V. Saferding,
None;
A. Puchner,
None;
E. Goncalvesalves,
None;
B. Niederreiter,
None;
S. Hayer,
None;
G. Schabbauer,
None;
M. Koenders,
None;
J. Smolen,
None;
K. Redlich,
None;
S. Blueml,
None.
« Back to 2014 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/loss-of-microrna-146a-exacerbates-inflammatory-arthritis/